National Academies Press: OpenBook
« Previous: Appendix C: Statement of Task
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×

Appendix D

Registered Attendees

Reza Alavi

Center for Medical Technology Policy

William Albuquerque

Genetic Alliance

C. Anthony Altar

AssureRx Health, Inc.

Eric Assaraf

Washington Research Group

David Bachinsky

Alpha-Genics

Judith Benkendorf

American College of Medical Genetics and Genomics

Sharon Bergquist

National Academy of Sciences

Paul Billings

Life Technologies

Bruce Blumberg

Kaiser Permanente

Juli Bollinger

Genetics and Public Policy Center

Denise Bonds

National Heart, Lung, and Blood Institute

Khaled Bouri

U.S. Food and Drug Administration

Chandra Branham

AdvaMed

Joel Brill

Predictive Health, LLC

Steven Brotman

AdvaMed

Jonca Bull

Novartis

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×

Wylie Burke

University of Washington

Khatereh Calleja

AdvaMed

C. Thomas Caskey

Baylor College of Medicine

Niranjana Chandrasekaran

Genetic Alliance

John Cogswell

Bristol-Myers Squibb

Nicholas Conti

Quest Diagnostics

Sara Copeland

Health Resources and Services Administration

Amy Cunniffe

Caris Life Sciences

Bernard Edelman

Vietnam Veterans of America

Russel Enns

Cepheid

W. Gregory Feero

National Human Genome Research Institute

Andrew Freedman

National Cancer Institute

Geoffrey Ginsburg

Duke University

Jonathan Gitlin

National Human Genome Research Institute

Judith Glassgold

Office of Rep. Sander Levin

Joseph Glick

Expertool Software

Federico Goodsaid

Vertex Pharmaceuticals

Mark Gorman

National Coalition for Cancer Survivorship

Johanna Gray

CRD Associates

David Gross

College of American Pathologists

Alberto Gutierrez

U.S. Food and Drug Administration

Chris Havasy

Presidential Commission for the Study of Bioethical Issues

Daniel Hayes

University of Michigan Comprehensive Cancer Center

C. J. Hoban

Multiple Myeloma Research Foundation

Louis Hochheiser

Humana, Inc.

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×

Richard Hodes

National Institute on Aging

Gillian Hooker

National Human Genome Research Institute

Louis Jacques

Centers for Medicare & Medicaid Services

Janet Jenkins-Showalter

Roche/Genentech

Michael Evan Johnson

SWIDE Effects LLC

Sharon Kardia

University of Michigan

James Kelly

Affymetrix

Mohamed Khan

Vancouver Cancer Centre

Christopher Khoury

PwC

Muin Khoury

Centers for Disease Control and Prevention

Vanessa King

Siemens Corporate Research

Brenda Kostelecky

National Cancer Institute

Jennifer Leib

HealthFutures, LLC

Emily Lenneville

Institute of Medicine

Debra Leonard

Weill Cornell Medical Center

Hallie Lewis

Cepheid

Rachel Lindor

Department of Health and Human Services

Kimberly Linthicum

Myriad Genetic Laboratories

Paul Lipkin

Kennedy Krieger Institute

Michele Lloyd-Puryear

Office of Rare Diseases Research, National Institutes of Health

Jenny Luray

BD

Anthony Magliocco

H. Lee Moffitt Cancer Center

Debra Mathews

Presidential Commission for the Study of Bioethical Issues

Robert McCormack

Veridex, LLC

Mary McGrane

U.S. Department of Agriculture

Kasinathan Muralidharan

Quest Diagnostics Nichols Institute

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×

Rachel Novak

U.S. Food and Drug Administration

Robert Nussbaum

University of California, San Francisco, School of Medicine

Steve Olson

Independent Consultant

Danielle Pambianco

HillCo HEALTH

Meeta Patnaik

Transtek Clinical Systems

Mary Pendergast

Pendergast Consulting

Michelle Penny

Eli Lilly and Company

Margaret Piper

Blue Cross and Blue Shield Association

Laura Povlich

American Association for the Advancement of Science Congressional Fellow—Office of Rep. Sander Levin

Aidan Power

Pfizer Inc.

Bruce Quinn

Foley Hoag LLP

Scott Rabuka

DNA Genotek

Turna Ray

GenomeWeb

Michael Reiner

Siemens Healthcare

Stephen Richardson

Genomic Health, Inc.

Allen Roses

Duke University

Tharini Sathiamoorthy

AdvaMedDx

Manon Schladen

Medstar Health Research Institute

Kevin Schulman

Duke University Medical Center

Joan Scott

National Coalition for Health Professional Education in Genetics

Beverlyn Settles-Reaves

Howard University

Steven Shak

Genomic Health, Inc.

Fay Shamanski

College of American Pathologists

Marilee Shelton-Davenport

National Research Council

Sophie Shen

The Brookings Institution

Vaidehi Sheth

Genetic Alliance

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×

Andy Shih

Autism Speaks

Sue Siegel

Mohr Davidow

Jennifer Skornik

Independent

Dennis Strickland

Pfizer Inc.

Katherine Johansen Taber

American Medical Association

Wendy Toler

Medscientia

Sean Tunis

Center for Medical Technology Policy

Martha Turner

American Nurses Association

Laura van‘t Veer

University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center

Michael S. Watson

American College of Medical Genetics and Genomics

Jennifer Webster

Kaiser Permanente Center for Heath Research

Susan Weiner

Children’s Cause for Cancer Advocacy

Cole Werble

The RPM Report

Catherine Wicklund

Northwestern University

Yining Xie

National Institutes of Health

Huichun Xu

National Institutes of Health

Jiwen Zhang

GE Healthcare

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×

This page intentionally left blank.

Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×
Page 79
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×
Page 80
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×
Page 81
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×
Page 82
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×
Page 83
Suggested Citation:"Appendix D: Registered Attendees." Institute of Medicine. 2012. Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/13359.
×
Page 84
Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary Get This Book
×
Buy Paperback | $35.00 Buy Ebook | $28.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The sequencing of the human genome and the identification of associations between specific genetic variants and diseases have led to an explosion of genomic-based diagnostic tests. These tests have the potential to direct therapeutic interventions, predict risk or onset of disease, or detect residual disease. As research progresses and an increasing number of associations are found, further tests will be developed that can aid in providing personalized treatment options for patients. However, the adoption of genomic diagnostic tests by health care providers has been limited due to a lack of evidence regarding the clinical utility of many tests. Health funders and practitioners lack the data necessary to distinguish which tests can improve practice or the clinical settings in which tests will provide the greatest value. The Roundtable on Translating Genomic-Based Research for Health held a workshop in November 2010 to determine what evidence is needed and how it is viewed by different stakeholders in order to develop genomic diagnostic tests of clinical value.

Genome-Based Diagnostics summarizes the presentations and discussions that took place throughout the workshop. Two presentations, in particular, sparked extensive discussion. One presentation proposed that all genomic diagnostic tests be reviewed and approved by the Food and Drug Administration. The other observed that venture capitalists are no longer investing substantially in the development of genomic diagnostic tests because of a lack of clarity surrounding regulatory and reimbursement pathways. Both presentations suggested the need for major changes in the systems used to develop, regulate, and reimburse genomic diagnostic tests. The report also presents the perspectives of different stakeholders in the development of genomic diagnostic tests. Each stakeholder group has a different set of needs and issues of importance, yet commonalities among them are apparent, such as the need to put patients and health outcomes at the center of discussion and action.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!